Nobutoshi Ando

6.7k citations
101 papers · 5.4k · 3 hit papers · h-index 32

Impact in

  • Surgery top 0.5%
    • Esophageal Cancer Research and Treatment
    • Esophageal and GI Pathology
    • Tissue Engineering and Regenerative Medicine
    • Gastric Cancer Management and Outcomes
    • Lung Cancer Diagnosis and Treatment
    • Lung Cancer Treatments and Mutations
    • Metastasis and carcinoma case studies

Papers in

    • Esophageal Cancer Research and Treatment 48
    • Esophageal and GI Pathology 21
    • Tissue Engineering and Regenerative Medicine 5
    • Gastric Cancer Management and Outcomes 23
    • Lung Cancer Treatments and Mutations 8
    • Tracheal and airway disorders 5

Nobutoshi Ando

94 papers receiving 5.2k citations

Nobutoshi Ando's Hit Papers

A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) 2011 · 1.1k citations
1.1k0+8+17Years since publication2505007501000

Peers

Nobutoshi Ando
Comparison fields: 5 of 104
  • Surgery 3.5k
  • Pulmonary and Respiratory Medicine 1.8k
  • Oncology 834
  • Gastroenterology 144
  • Critical Care and Intensive Care Medicine 83
Replace Michio Maeta with:
Michio Maeta Japan
Yasunori Akutsu Japan
Konstantinos I. Votanopoulos United States
Naoto Gotohda Japan
Hisashi Ikoma Japan
Jinsil Seong South Korea
Shinsuke Takeno Japan
Isamu Hoshino Japan
Hiromichi Kanehiro Japan
Minoru Kitago Japan
Nobutoshi Ando relative to Michio Maeta Japan Michio Maeta's profile →
Citations per field
00.5×5.9×
Michio Maeta · 1×
Citations per year

Countries citing papers authored by Nobutoshi Ando

Since Specialization
Citations

This map shows the geographic impact of Nobutoshi Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobutoshi Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobutoshi Ando more than expected).

Fields of papers citing papers by Nobutoshi Ando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobutoshi Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobutoshi Ando. The network helps show where Nobutoshi Ando may publish in the future.

Co-authors

The 25 scholars most cited alongside Nobutoshi Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nobutoshi Ando Line = papers co-authored together Nobutoshi Ando links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)
Hit paper breakdown →
20111106
2
Surgery Plus Chemotherapy Compared With Surgery Alone for Localized Squamous Cell Carcinoma of the Thoracic Esophagus: A Japan Clinical Oncology Group Study—JCOG9204
Hit paper breakdown →
2003561
3
Improvement in the Results of Surgical Treatment of Advanced Squamous Esophageal Carcinoma During 15 Consecutive Years
Hit paper breakdown →
2000478
4 2000236
5 2013236
6 1997220
7 2016168
8 1989162
9 2016151
10 1987134
11 2015127
12
Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma.
1991118
13 200998
14 201297
15 200979
16 199875
17 199871
18 199970
19 198866
20 200259

About Nobutoshi Ando

Nobutoshi Ando is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Gastroenterology and Epidemiology, having authored 101 papers that have together received 5.4k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (48 papers), Gastric Cancer Management and Outcomes (23 papers), Esophageal and GI Pathology (21 papers), Lung Cancer Treatments and Mutations (8 papers), Gastrointestinal Tumor Research and Treatment (6 papers), Tracheal and airway disorders (5 papers), Tissue Engineering and Regenerative Medicine (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Surgery (3.5k citations), Pulmonary and Respiratory Medicine (1.8k citations), Oncology (834 citations), Gastroenterology (144 citations) and Critical Care and Intensive Care Medicine (83 citations). Nobutoshi Ando has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Soji Ozawa, Yuko Kitagawa, Masaki Kitajima, Masakazu Ueda, Haruhiko Fukuda, Masayuki Shinoda, Hiroyasu Igaki, Osahiko Abe, Nobuyoshi Shimizu and Norio Aoyama. Their work appears in journals such as International Journal of Cancer, ASAIO Journal, Japanese Journal of Clinical Oncology, Esophagus and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact